The Dr. Gabrielle Lyon Show cover image

Is Ozempic Actually Safe? CEO of Major Pharmacy Speaks Out | Shaun Noorian, CEO

The Dr. Gabrielle Lyon Show

00:00

Navigating Healthcare Access and Medication Pricing

This chapter examines the challenges of accessing GLP-1 medications like Ozempic and Wagovi within the healthcare system, emphasizing the impact of traditional insurance and pharmaceutical dynamics. It discusses the potential of emerging healthcare models that prioritize affordability and telemedicine, while also addressing regulatory changes affecting compounding pharmacies and patient access. Furthermore, the chapter explores the competitive landscape between large pharmaceutical companies and smaller facilities, shedding light on the implications for medication pricing and access.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app